|
The latest report from PMR - Pharmaceutical and Healthcare Market in Poland 2009 - provides information on the size of the pharmaceutical market in Poland in 2002-2008 and market size projections for 2009-2011. The main forecasts estimate the size of the total market, pharmacy and hospital segment, Rx, foreign and domestic drugs, generic and innovative medicines, and expected growth for all the main ATC categories. For all the abovementioned drug groups, the forecasts are made for 2009-2011 by total segment and by Rx segment only. The report presents market shares of the key players, both as consortiums and as individual companies. Market size and analysis are also broken down by each drug category for easy referencing. The ATC categories are analysed by total sales as well as Rx sales. Information is also provided on the best-selling preparations in each ATC category.
The report offers insights into ongoing trends, taking a closer look at areas of growth and decline. Factors that influence the market, from epidemiology to consumer behaviour, are studied and presented for your thorough understanding of the market. Economic data, such as employment and cost-revenue analysis of the pharmaceutical sector, are also covered.
Our analysis also takes into account the latest changes in reimbursement and legislation (latest and expected). The impact of global financial crisis has also been analysed and taken into consideration in the forecasts provided for the size of the Polish pharmaceutical and healthcare market by the PMR team of pharmaceutical analysts and economists.
List of graphs
- Value (PLN bn) and y-o-y change of sales on the pharmaceutical market in Poland, 2002-2011
- Percentage shares of OTC and Rx drugs in the pharmacy market in Poland, 2008
- Value (PLN bn) and y-o-y change of sales on the pharmaceutical market in Poland, 2002-2011
- Value (PLN bn) and y-o-y change of sales of Rx drugs on the pharmaceutical market in Poland, 2002-2011
- Share of domestic and foreign drugs in value of pharmacy sales in Poland, 2002-2008
- Share of domestic and foreign drugs in value of Rx pharmacy sales in Poland, 2002-2008
- Share of domestic and foreign drugs in number of packages sold in Poland, 2002-2008
- Share of domestic and foreign Rx drugs in number of packages sold in Poland, 2002-2008
- Value (PLN bn) and y-o-y change of sales of domestic drugs in Poland, 2002-2011
- Value (PLN bn) and y-o-y change of sales of foreign drugs in Poland, 2002-2011
- Sales value of generic and original drugs in Poland (PLN m), 2004-2007
- Sales volume of packages of generic and original drugs in Poland (million of units), 2004-2007
- Value share of generics in Polish pharmaceutical market, Q3 2007-Q3 2008
- Shares of generic and original drugs in Rx market value in Poland (%), 2004-2007
- Shares of original and generic drugs in the value of Polish pharmaceutical market relative to select countries (%), June 2007-June 2008
- Quantitative share of generics in Polish pharmaceutical market, Q3 2007-Q3 2008
- Volume share of generic and original drugs in Rx market in Poland (%), 2004-2007
- Volume share of generic drugs in Polish Rx market relative to select countries (%), June 2007-June 2008
- Value (PLN bn) and y-o-y change of hospital pharmaceutical market in Poland, 2000-2011
- Debt due from independent public healthcare centres in Poland (PLN bn), Q1 2005-Q4 2008
- Total debt of independent healthcare centres in Poland (PLN m), Q4 2004-Q4 2008
- NFZ spending on drug therapy programmes and y-o-y change in Poland (PLN m), 2005-2009
- NFZ spending on chemotherapy and y-o-y change in Poland (PLN m), 2006-2009
- Share of unused funds allocated to chemotherapy reimbursement in Poland, H1 2008
- Average drug prices on pharmacy market in Poland (PLN), 2002-2008
- Change in prices of reimbursed drugs in Polish pharmacies, January-December 2008
- Average drug prices in in-patient treatment in Poland (PLN), 2004-2007
- Average prices of domestic and foreign drugs sold on the Polish pharmacy market (PLN), 2002-2008
- Average prices of domestic and foreign Rx drugs sold on the Polish pharmacy market (PLN), 2002-2008
- Average prices of domestic and foreign refunded drugs sold on the Polish pharmacy market (PLN), 2002-2008
- Average prices of innovative and generic Rx drugs on pharmacy market in Poland (PLN), 2004-2007
- Average drug prices by ATC groups in Poland (PLN), 2003, 2007 and 2008
- Average Rx drug prices by ATC groups in Poland (PLN), 2003, 2007 and 2008
- Highest growth rates in ATC subgroups on Polish pharmacy market, 2008
- Highest growth rates in ATC subgroups on Polish pharmacy Rx market, 2008
- Greatest decreases in ATC subgroups on Polish pharmacy market, 2008
- Greatest decreases in ATC subgroups on Polish Rx pharmacy market, 2008
- Average drug prices of largest pharma concerns in Poland (PLN), 2006-2008
- Average Rx drug prices of largest pharma concerns in Poland (PLN), 2006-2008
- Average manufacturer price (MSRP) per comparable drug unit in Poland and other European countries, 2008
- Value of the NFZ’s expenditure for refunded drugs compared to value of expenditure for healthcare in Poland (PLN m), 2003-2009 62] Percentage share of reimbursement in pharmacy trade in Poland, H1 2006- H2 2008
- Drug reimbursement in Poland by reimbursement type, in value terms, 2004-2007
- Drug reimbursement in Poland by reimbursement type, in volume terms, 2004-2007
- Structure of drug reimbursement in Poland, by ATC groups, 2007
- Structure of sales of reimbursed drugs in Poland for domestic and foreign preparations, by value, 2002-2008
- Structure of sales of reimbursed drugs in Poland for domestic and foreign preparations, by volume, 2002-2008
- Drug refund levels in Poland and select European countries, 2007
- Value ($ m) and y-o-y change of drug exports from Poland, 1996-H1 2008
- Countries of destination for Polish drug exports by value of exports (PLN m) and y-o-y change, 2007
- Countries of destination for Polish drug exports by value of exports (PLN m) and y-o-y change, H1 2008
- Top increases in value of drug exports from Poland, by country, H1 2008
- Value ($ bn) and y-o-y change of drug imports to Poland, 1996-H1 2008
- Countries of origin of drug imports to Poland (PLN m) and y-o-y change in import value, 2007
- Countries of origin of drug imports to Poland (PLN m) and y-o-y change in import value, H1 2008
- Top increases in drug imports to Poland, by country, H1 2008
- Pharmacy market by ATC categories in value terms in Poland, 2008
- Pharmacy Rx market by ATC categories in value terms in Poland, 2008
- Pharmacy market by ATC categories in volume terms in Poland, 2008
- Pharmacy Rx market by ATC categories in volume terms in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs used in alimentary tract and metabolic diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in alimentary tract and metabolic diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of largest categories of drugs used in alimentary tract and metabolic diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of largest categories of Rx drugs used in alimentary tract and metabolic diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs used in cardiovascular diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in cardiovascular diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of largest categories of drugs used in cardiovascular diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of largest categories of Rx drugs used in cardiovascular diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs used in central nervous system diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in central nervous system diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of largest categories of drugs used in central nervous system diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of largest categories of Rx drugs used in central nervous system diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs used in respiratory system diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in respiratory system diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of drugs used in respiratory system diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx drugs used in respiratory system diseases in Poland, 2008
- Incidence of asthma and wheezing/whistling in the chest in urban and rural Poland, 2006-2008
- Incidence of allergic rhinitis and rhinitis in rural and urban Poland, 2006-2008
- Sales value (PLN m) and y-o-y change of anti-infectives in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx anti-infectives in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of largest categories of anti-infectives in Poland, pharmacy market and Rx market, 2008
- Sales value (PLN m) and y-o-y change of drugs used in musculo-skeletal diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in musculo-skeletal diseases in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of drugs used in musculo-skeletal diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx drugs used in musculo-skeletal diseases in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs affecting genito-urinary system in Poland, 2002-2011
- Value (PLN m) and y-o-y change of sales of Rx drugs affecting genito-urinary system in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of drugs affecting genito-urinary system in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx drugs affecting genito-urinary system in Poland, 2008
- Sales value (PLN m) and y-o-y change of dermatologicals in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx dermatologicals in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of largest categories of dermatologicals in Poland, 2008
- Sales value (PLN m) and y-o-y change of largest categories of Rx dermatologicals in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs used in diseases of the blood and blood forming organs in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in diseases of the blood and blood forming organs in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of largest categories of drugs used in diseases of the blood and blood forming organs in Poland, 2008
- Sales value (PLN m) and y-o-y change of largest categories of Rx drugs used in diseases of the blood and blood forming organs in Poland, 2008
- Sales value (PLN m) and y-o-y change of antineoplastic and immunomodulating agents in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx antineoplastic and immunomodulating agents in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of antineoplastic and immunomodulating agents in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx antineoplastic and immunomodulating agents in Poland, 2008
- Sales value (PLN m) and y-o-y change of drugs used in disorders of the sensory organs in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx drugs used in disorders of the sensory organs in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of drugs used in disorders of the sensory organs in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx drugs used in disorders of the sensory organs in Poland, 2008
- Sales value (PLN m) and y-o-y change of systemic hormonal preparations in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx systemic hormonal preparations in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of systemic hormonal preparations in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx systemic hormonal preparations in Poland, 2008
- Sales value (PLN m) and y-o-y change of parasitology drugs in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of Rx parasitology drugs in Poland, 2002-2011
- Sales value (PLN m) and y-o-y change of categories of parasitology drugs in Poland, 2008
- Sales value (PLN m) and y-o-y change of categories of Rx parasitology drugs in Poland, 2008
- Sales structure of ATC group “various” in Poland, pharmacy market, 2008
- Sales structure of ATC group “various” in Poland, Rx market, 2008
- Size of manufacturers of basic pharmaceutical products (NACE 21.1) in Poland, 2007
- Size of drugs and pharmaceutical preparations’ manufacturers (NACE 21.2) in Poland, 2007
- Output of selected pharmaceutical products in Poland (tonnes), 2000-2007
- Net revenues (PLN bn) and y-o-y change of Polish pharmaceutical sector, 2002-2007
- Sales profit and y-o-y change of the pharmaceutical sector in Poland (PLN m), 2005-2007
- Wages in pharmaceutical sector in Poland (PLN), 2006-2007
- Structure of investments in Polish pharma industry, by NACE code, 2007
- Cost estimate value (PLN m) and y-o-y change of new investments in Polish pharma industry, 2004-2007
- Value of new investments in Polish pharma, by NACE type, 2007
- Outlays on tangible assets in Polish pharma industry (PLN m), 2004-2007
- Top 10 pharma concerns on the Polish pharmacy market in terms of sales value, 2008
- Market shares of top 10 pharma concerns by sales value in sales volume (number of packages sold) on pharmacy market in Poland, 2008
- Top 10 pharma manufacturers on the Polish pharmacy market in terms of sales value, 2008
- Market shares of top 10 pharma manufacturers by sales value in sales volume (number of packages sold) on pharmacy market in Poland, 2008
- Top 10 pharma concerns on the Polish Rx pharmacy market in terms of sales value, 2008
- Market shares of top 10 pharma concerns by sales value in sales volume (number of packages sold) on Rx pharmacy market in Poland, 2008
- Top 10 pharma manufacturers on the Polish Rx pharmacy market in terms of sales value, 2008
- Market shares of top 10 pharma manufacturers by sales value in sales volume (number of packages sold) on Rx pharmacy market in Poland, 2008
- Novartis’ sales (PLN m) and y-o-y change on Polish pharmacy market, 2002-2008
- Novartis’ Rx sales (PLN m) and y-o-y change on Polish pharmacy market, 2002-2008
- GSK sales (PLN m) and y-o-y growth on Polish pharmacy market, 2002-2008
- GSK Rx sales (PLN m) and y-o-y change on Polish pharmacy market, 2002-2008
- Polpharma sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Polpharma Rx sales (PLN m) and y-o-y change on Polish pharmacy market, 2002-2008
- Sanofi-Aventis sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Sanofi-Aventis Rx sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Servier sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Roche sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Roche Rx sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Krka sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Krka Rx sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Krka’s sales performance (€ m) and y-o-y change in Central Europe, Q1 2009
- US Pharmacia sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Novo Nordisk sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Adamed sales (PLN m) and y-o-y change on the Polish pharmacy market, 2002-2008
- Poland’s population (million), 2000-2035
- Fertility rate in Poland and other select countries, 2008
- Age structure of Polish population, 2000 and 2008
- Population forecast for selected age groups in Poland (million), 2004-2035
- Structure of health insurance spending in Poland, by age, in 2007, 2025 and 2050
- Life expectancy at birth in Poland (years), 1990-2035
- Expected lifespan at birth for men in Poland compared with select European countries, 1990 and 2006
- Expected lifespan at birth for women in Poland compared with select European countries, 1990 and 2006
- Polish population by gender, 2008
- Polish population by place of residence, 2008
- Did you suffer from the illness/ailment in the last year? Poland and EU average, 2008
- Do you or someone in your household suffer from the mentioned illnesses/ailments? Poland, 2008
- Deaths by main causes (% of total deaths) in Poland, 1990-2006
- Surplus mortality in persons aged 25-64 in Poland relative to EU-27 average, by cause of death and gender, 1999 and 2006
- Surplus mortality in persons aged 25-64 in Poland relative to EU-27 average, by disease and gender, 2006
- Deaths caused by cardiovascular diseases, by type of disease, Poland, 2006
- Number of cases of malignant tumours in men in Poland, by tumour localisation (‘000), 2006
- Incidence of malignant tumours in men in Poland, by type of cancer, 1999, 2002 and 2006
- Mortality rate among men caused by malignant tumorus, by type of cancer (‘000), 2006
- Number of cases of malignant tumours in women in Poland, by tumour localisation (‘000), 2006
- Incidence of malignant tumours in women in Poland, by type of cancer, 1999, 2002 and 2006
- Mortality rate among women caused by malignant tumours, by type of cancer, Poland (‘000), 2006
- Incidence of flu in Poland (million), 1970-2008
- Morbidity rate (number of cases per 100,000 inhabitants) for hepatitis virus C in Poland, 1999-2007
- Assessment of own health in Poland, 2008
- Reasons for poor health in Poland in opinion of the respondents, 2008
- What do Poles and Europeans do to stay healthy?, 2008
- The 10 most frequently used sources on health information in Poland and their reliability, 2008
- Doctors informing Polish patients about cheaper equivalents of expensive drugs, 2001, 2003, 2005 and 2007
- Poles’ opinions on Polish equivalents of foreign drugs, 2005 and 2007
- Respondents’ opinions about generic drugs in Poland and other European countries, 2008
- Poles attitude towards innovative drugs and treatment, 2008
- Factors influencing the purchase of OTC drugs in Poland and other European countries, 2008
- The most prevalent opinions about OTC drugs in Poland and Europe, 2008
- Most often purchased OTC drugs in Poland, April 2007-April 2008
- Where do you purchase OTC drugs in Poland? 2007
- Consumer confidence in online drug distribution channels in Poland, 2008
- Most popular reasons not to purchase OTC drugs in e-pharmacies in Poland, 2008
- Use of OTC and Rx drugs to treat illnesses/ailments in Poland, 2008
- GDP growth in Poland (%), 2005-2011
- Inflation rate in Poland (%), 2005-2011
- Unemployment rate in Poland (%), 2005-2011
- Gross average monthly wages in Poland (PLN), 2005-2008
- End statistics for harmonisation of medicinal products in Poland, January 2009
- Revenues and net profit of Cefarm Bialystok in Poland (PLN m), 2007-2008
- Revenues and net profit of CF Cefarm in Poland (PLN m), 2007-2008
- Pharmaceuticals distribution in Poland, 2007
- Number of pharmaceutical warehouses owned by the largest wholesalers in Poland, 2008
- Wholesaler count in Poland and select European countries, 2007
- Market share of largest pharmaceutical wholesalers in Poland, 2008
- PGF’s total revenues, net profits and y-o-y change (PLN m), 2007-2008
- PGF’s total revenues, net profits and y-o-y change (PLN m), Q1 2009
- PGF sales structure, 2008
- Torfarm’s total revenues, net profits and y-o-y change in Poland (PLN m), 2007-2008
- Torfarm’s total revenues, net profits and y-o-y change in Poland (PLN m), Q1 2009
- Farmacol’s total revenues, net profits and y-o-y change in Poland (PLN m), 2007-2008
- Farmacol’s total revenues, net profits and y-o-y change in Poland (PLN m), Q1 2009
- Prosper’s total revenues, net profits and y-o-y change in Poland (PLN m), 2007-2008
- Prosper’s total revenues, net profits and y-o-y change in Poland (PLN m), Q1 2009
- OPG Groep’s sales and y-o-y change in Poland (€ m), 2007-2008
- OPG Groep’s sales and y-o-y change in Poland (€ m), Q1 2009
- Number of pharmacies and pharmacy outlets in Poland (thousands), 1990-2008
- Average monthly pharmacy sales in Poland (PLN ‘000) and y-o-y change, January 2007-December 2008
- Pharmacy chains in Poland (pharmacy count), January 2009
- The largest independent pharmacy chains in Poland, April 2009
- Online pharmacies’ sales of medicinal products and cosmetics (PLN m), 2007 and 2013
- The biggest online pharmacies in Poland (number of unique users in thousand), August 2008
- Total healthcare sector’s financing (PLN bn) in Poland, 2000-2007
- Sources of financing in healthcare sector in Poland, 2007
- Forecast for total financing and spending of public healthcare sector (PLN bn) in Poland, 2008-2050
- Proceeds from health insurance premiums (PLN m) in Poland, 2000-2007
- State budget expenditure on public health insurance premiums in Poland, by insured, 2007 and 2008
- Healthcare system spending in Poland (PLN bn), 2004-2007
- Healthcare spending in Poland, by function, 2006
- Healthcare spending in Poland, by provider groups, 2006
- State budget spending on health care (PLN m) in Poland, 1999-2007
- Funds spent on health care by individual local government units in Poland, 2007
- NFZ expenditure on reimbursement in Poland (PLN bn), 2001-2007
- NFZ’s net financial result in Poland (PLN m), 2004-2007
- Number of public and non-public hospitals in Poland, 2001-2007
List of tables
- Value (PLN m) and y-o-y change of pharmaceutical sales on the pharmacy market in Poland, by ATC groups, 2002-2008
- Value (PLN m) and y-o-y change of Rx pharmaceutical sales on the pharmacy market in Poland, by ATC groups, 2002-2008
- Value (PLN bn) and y-o-y change of pharmaceutical market in Poland, pharmacy market, Rx market and reimbursed drugs, 2002-2008
- Volume (million of packages) and y-o-y change of sales on the pharmaceutical market in Poland, pharmacy market, Rx market and reimbursed drugs, 2002-2008
- Value (PLN bn) and y-o-y change of sales of domestic and foreign drugs in Poland, pharmacy market, Rx market, and reimbursed drugs, 2002-2008
- Volume (million of packages) and y-o-y change of sales of domestic and foreign drugs in Poland, pharmacy market, Rx market, and reimbursed drugs, 2002-2008
- Oncology drug therapy programmes in Poland, H1 2008
- Hepatitis therapeutic programmes in Poland, 2008
- Active substances which generated the highest reimbursement costs in Poland, 2006-H1 2008
- Products generating highest drug reimbursement costs in Poland, 2006-2007
- Products with the greatest quantity of reimbursed packages in Poland, 2006-2007
- Manufacturers whose products generated the highest reimbursement value in Poland, 2007
- Sales volume (million of packages) and y-o-y change of largest categories of drugs used in alimentary tract and metabolic diseases in Poland, pharmacy market and Rx market 2008
- Top 10 drugs used in alimentary tract and metabolic diseases in Poland, by sales value, 2008
- Value (PLN m) and y-o-y change of net profit and pre-tax profit of Polish pharmaceutical sector, 2002-2007
- Percentage share of individual types of costs in total operating expenses of Polish pharmaceutical sector (%), 2002-2007
- Employment in Polish pharmaceutical sector (staffing levels and y-o-y change), 2001-2007
- Labour productivity in Polish pharmaceutical sector (PLN’000 per capita), 2001-2007
- Major foreign investment projects in Polish pharmaceutical industry, 2007
- Top 20 pharma concerns on the Polish pharmacy market, in terms of sales value and volume, 2008
- Top 20 pharma manufacturers on the Polish pharmacy market, in terms of sales value and volume, 2008
- Top 20 pharma concerns on the Polish Rx pharmacy market, in terms of sales value and volume, 2008
- Top 20 pharma manufacturers on the Polish Rx pharmacy market, in terms of sales value and volume, 2008
- Novartis’ products among best sellers of individual ATC categories in Poland, 2008
- Sandoz products among best sellers of individual ATC categories in Poland, 2008
- GSK products among best sellers of individual ATC categories in Poland, 2008
- Polpharma products among best sellers of individual ATC categories in Poland, 2008
- Sanofi-Aventis products among best sellers of individual ATC categories in Poland, 2008
- Servier products among best sellers of individual ATC categories in Poland, 2008
- Roche products among best sellers of individual ATC categories in Poland, 2008
- Krka products among best sellers of individual ATC categories in Poland, 2008
- US Pharmacia products among best sellers of individual ATC categories in Poland, 2008
- Novo Nordisk products among best sellers of individual ATC categories in Poland, 2008
- Adamed products among best sellers of individual ATC categories in Poland, 2008
- Number of persons treated in psychiatric care out-patient clinics and all-day hospital wards in Poland, by select diagnosis, 2000-2006
- Number of persons with diabetes in Poland and in other countries of Central and Eastern Europe (‘000), 1994-2010
- Official retail margins for reimbursed drugs provided in the draft of the minor amendment to the Pharmaceutical Law in Poland, September 2008
- Torfarm’s acquisition record, 2007-2009
- Financing from healthcare premiums (PLN m) in Poland, by ZUS and KRUS inflows, 2000-2007
- Costs of financial tasks from the state budget (PLN m) in Poland, 2004-2007
- Structure of local government unit spending on health care (PLN m) in Poland, by healthcare division, 2007
- Persons insured with the NFZ in Poland, 2004-2007
- Registered medical personnel in Poland, 2001-2007
- Medical personnel employed at healthcare facilities in Poland, 2001-2007
- Specialists employed at healthcare facilities, 2006-2007
- Average net monthly remuneration in independent public healthcare centres based on employment contracts in Poland, by select professional groups, June 2007
- Number of healthcare centres (ZOZ) and outpatient assistance in Poland, 2000-February 2009
- Primary healthcare facilities (POZ) in Poland, 2003-2007
- Number of beds and hospitalised in general hospitals in Poland, 2005-2007
- Poles' monthly healthcare spending (PLN per capita), 2007
- Main reasons for hospitalisation in Poland, 2006
description |
table of contents |
table of graphs and tables |
leaflet |
free article |
request more info
|
Polish version also available!
